Tipifarnib and Sorafenib Tosylate in Treating Patients With Biopsiable Advanced Cancer
Clinical trial NCT00244972 · COMPLETED
Trial details
- NCT number
- NCT00244972
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-10-01
- Primary completion
- 2017-03-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.